028300.KQ HLB | KR7028300002
Company Profile
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. Additionally, it develops biological drugs with MoA to infectious diseases. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
Latest News
Dreame Technology Redefines Hands-free Cleaning with the Launch of the Dreame D30 Ultra Robot Vacuum
PR Newswire • 07/27/2026
Netflix Is Down 41% in 1 Year. Could the Sell-Off Be Nearing an End?
Motley Fool • 07/27/2026
Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio
PR Newswire • 07/27/2026
| Sector | Healthcare |
| Industry | Biotechnology |
| Website | https://www.hlbbio.co.kr/ |
| Audit Risk | 1 |
| Board Risk | 6 |
| Overall Risk | 7 |
| Market Cap | 4.18T |
| Enterprise-to-Revenue | 52.24 |
| Enterprise-to-EBITDA | -50.58 |
| Earnings Date | |
| Earnings Call Date |